Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595685 | SCV000705172 | uncertain significance | not provided | 2016-12-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003509576 | SCV004246761 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024771 | SCV005032983 | likely benign | Cardiovascular phenotype | 2023-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |